Fulgent Genetics (FLGT) Total Current Liabilities (2015 - 2026)

Fulgent Genetics has disclosed Total Current Liabilities across 12 years of filings, most recently posting $90.1 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $90.1 million, up 36.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $90.1 million (up 36.74% YoY), and the FY2025 annual result was $85.0 million, up 16.55% from the prior year.
• Total Current Liabilities came in at $90.1 million for Q1 2026 at Fulgent Genetics, up from $85.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $141.7 million in Q1 2022 to a low of $61.4 million in Q3 2023.
• The 5-year median for Total Current Liabilities is $75.8 million (2024), against an average of $83.8 million.
• Across the five-year window, Total Current Liabilities plunged 49.17% in 2023 and jumped 36.74% in 2026, its largest moves.
• Fulgent Genetics' Total Current Liabilities stood at $88.1 million in 2022, then slipped by 17.13% to $73.0 million in 2023, then dropped by 0.16% to $72.9 million in 2024, then climbed by 16.55% to $85.0 million in 2025, then rose by 6.08% to $90.1 million in 2026.
• The last three Total Current Liabilities figures came in at $90.1 million (Q1 2026), $85.0 million (Q4 2025), and $72.4 million (Q3 2025), per Business Quant data.